Singapore Study Tackles Women's Midlife Health Gap

Women spend 25% more of their lives in poorer health than men, yet they've been largely left out of nutrition research until now.

Singapore's Agency for Science, Technology and Research (A*STAR) and global health company Haleon just launched a major clinical study focused entirely on metabolic health in midlife Asian women. The ISMOS study will examine how multivitamin and mineral supplements affect blood sugar, cholesterol, blood pressure, and overall wellbeing during menopause.

This population has been dramatically underrepresented in global health research, even as they face unique physiological changes that increase vulnerability to metabolic syndrome. Metabolic syndrome combines several risk factors like high blood pressure and unhealthy cholesterol levels that significantly raise the chances of type 2 diabetes and heart disease.

The research builds on promising earlier findings from Singapore's GUSTO birth cohort study. That analysis found midlife women with higher vitamin levels showed more favorable metabolic markers, including lower blood sugar and cholesterol, plus better mental wellbeing and mobility.

The timing couldn't be more critical. Metabolic health issues are surging across Asia, driven by aging populations, increasingly busy lifestyles, and insufficient micronutrients from food alone.

Professor Johan Eriksson, Executive Director of A*STAR's Institute for Human Development and Potential, emphasized the study will generate locally and regionally relevant evidence on preventive health and healthy aging. Supporting women's health during midlife matters not just for individual wellbeing, but for entire families, communities, and economies.

The Ripple Effect

The economic case for investing in women's health is compelling. The World Economic Forum estimates that every dollar invested in women's health generates up to three dollars in economic returns through improved productivity and reduced healthcare costs.

By focusing research on a population that has historically been overlooked, this partnership represents a shift toward more inclusive science. When researchers study diverse populations, they create solutions that work for real people in real communities, not just theoretical averages.

The collaboration reflects a broader commitment to preventive healthcare approaches that empower individuals to take charge of their own health during critical life transitions.

This study is giving midlife Asian women something they've rarely had in medical research: a seat at the table.